View in EDS

2779P Phase Ib-II trial of tumor-loaded monocyte-derived dendritic cell vaccination plus atezolizumab in ES-SCLC.

Saved in:
Bibliographic Details
Title: 2779P Phase Ib-II trial of tumor-loaded monocyte-derived dendritic cell vaccination plus atezolizumab in ES-SCLC.
Authors: Gonzalez Cao, M.1 (AUTHOR), Sistere, M.2 (AUTHOR), Moran Bueno, M.T.3 (AUTHOR), Reguart, N.4 (AUTHOR), Meyerhans, A.2 (AUTHOR), Cabezon, R.5 (AUTHOR), Aguilar Hernandez, A.1 (AUTHOR), Roman, R.6 (AUTHOR), Molina-vila, M.A.6 (AUTHOR), Birgin, K.2 (AUTHOR), Domenjo, E.2 (AUTHOR), Pique, G.2 (AUTHOR), Moya Horno, I.7 (AUTHOR), Cirera, L.8 (AUTHOR), Esparre, C.1 (AUTHOR), Drozdowskyj, A.1 (AUTHOR), Martinez, E.6 (AUTHOR), Rosell, R.1 (AUTHOR), Otero, M.J.5 (AUTHOR), Benitez-Ribas, D.5 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1478-S1478. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.08.3390